Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-02-24
2000-11-28
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 3, 514592, 514635, 514866, A61K 31425, A61K 3828, A61K 31175, A61K 31155
Patent
active
061536326
ABSTRACT:
This invention is directed to a novel method and composition for the treatment of diabetes mellitus (Type I, Impaired Glucose Tolerance ["IGT"]and Type II). More specifically, this invention pertains to a novel method of treating diabetes mellitus by incorporating a therapeutic amount of one or more insulin sensitizers along with one or more of an orally ingested insulin, an injected insulin, a sulfonylurea, a biguanide or an alpha-glucosidase inhibitor for the treatment of diabetes mellitus.
REFERENCES:
patent: 4708868 (1987-11-01), Brickl et al.
patent: 4849405 (1989-07-01), Ecanow
patent: 4873080 (1989-10-01), Brickl et al.
patent: 4963526 (1990-10-01), Ecanow
patent: 5206219 (1993-04-01), Desai
patent: 5422125 (1995-06-01), Skyler et al.
patent: 5595763 (1997-01-01), Guinovart et al.
Weinstock et al., Pioglitazone. In vitro effects on rat hepatoma cells and in vivo liver hypertrophy in KKAy mice, (1997) abstract.
Windolz et al., The Merck Index, Tenth Ed. (1983) pp. 723 and 724, abstract No. 4866.
LandOfFree
Method and composition for the treatment of diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for the treatment of diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for the treatment of diabetes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726225